September 28, 2021
11:15 a.m. PDT / 2:15 p.m. EDT
Advancements in mRNA Capping and Manufacturing
Director, Business Development GMP, TriLink BioTechnologies
mRNA has revolutionized the field of vaccines and TriLink has been at the forefront. In this presentation, we demonstrate the advantages of CleanCap®
co-transcriptional capping and advancements in manufacturing to enable cost-effective vaccine production. With the capability of delivering up to multigram-quantity custom mRNAs under either non-GMP or GMP conditions, TriLink is the experienced development partner for research and clinical studies.
Followed by live Q&As.